6,6'-dicorynomycolyl trehalose has been researched along with Leishmaniasis, Visceral in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, N; Bhowmick, S; Das, A; Ravindran, R | 1 |
| Ali, N; Maji, M; Ravindran, R | 1 |
| Ali, N; Maji, M; Mazumder, S | 1 |
3 other study(ies) available for 6,6'-dicorynomycolyl trehalose and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Antigens, Protozoan; BCG Vaccine; Cord Factors; Female; Immunity, Humoral; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Lipid A; Mice; Time Factors | 2010 |
Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route.
Topics: Adjuvants, Immunologic; Animals; Antigens, Protozoan; Cells, Cultured; Chemical Phenomena; Cord Factors; Immunity, Active; Immunity, Cellular; Immunologic Memory; Injections, Subcutaneous; Interferon-gamma; Interleukin-4; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Lipid A; Liposomes; Liver; Mice; Mice, Inbred BALB C; Phospholipids; Specific Pathogen-Free Organisms; Spleen | 2012 |
Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection.
Topics: Adjuvants, Immunologic; Animals; Cord Factors; Cytokines; Disease Models, Animal; Female; Humans; Injections, Subcutaneous; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Lipid A; Liposomes; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Nitric Oxide; Phosphatidylcholines; Th1 Cells; Vaccination; Vaccines, Synthetic | 2011 |